rxstat › Classes › Antiglaucoma Preparations And Miotics
Antiglaucoma Preparations And Miotics: shortage status in Canada
15 of the 18 antiglaucoma preparations and miotics rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Acetazolamide Widespread shortage 2 of 3 reported products affected · est. return Jan 1, 2027
Levobunolol (Betagan) Widespread shortage 2 of 4 reported products affected
Pilocarpine (Isopto Carpine) Widespread shortage 4 of 6 reported products affected
Timolol (Timoptic-Xe) Widespread shortage 6 of 12 reported products affected · est. return Jul 30, 2027
Timolol Brimonidine (Combigan) Widespread shortage 3 of 3 reported products affected · est. return Oct 2, 2026
Timolol Latanoprost (Xalacom) Widespread shortage 4 of 8 reported products affected · est. return Sep 29, 2026
Timolol Travoprost (Duotrav Pq) Widespread shortage 2 of 2 reported products affected · est. return Oct 19, 2026
Acetylcholine Chloride (Miochol-E) Partial shortage 1 of 1 reported products affected · est. return Oct 1, 2026
Bimatoprost (Vistitan) Partial shortage 1 of 2 reported products affected
Brimonidine (Alphagan P) Partial shortage 2 of 9 reported products affected · est. return Aug 28, 2026
Dipivefrin Partial shortage 1 of 1 reported products affected
Dorzolamide (Trusopt) Partial shortage 1 of 5 reported products affected · est. return Aug 28, 2026
Latanoprost (Xalatan) Partial shortage 4 of 11 reported products affected · est. return Aug 25, 2026
Timolol Dorzolamide (Cosopt) Partial shortage 2 of 11 reported products affected · est. return Aug 7, 2026
Travoprost (Travatan Z) Partial shortage 2 of 5 reported products affected · est. return Aug 21, 2026
Apraclonidine (Iopidine) No current shortage
Betaxolol (Betoptic S) Discontinued 0 of 1 reported products affected
Methazolamide No current shortage
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.